November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- Jupiter Medical Center, Hospital for Special Surgery team on orthopedic care in South Florida
- Press Ganey announces 2025 Human Experience Award recipients
- Group of experts petition WHO to advocate for universal respirator use in health care
- Duke study links stress to poorer surgical recovery outcomes for older adults
- NAPA expands Bon Secours anesthesia relationship via Mary Immaculate Hospital deal
- BayCare previews new children's hospital to open in 2030
- Accreditation 360: Adjustments and opportunities
- CMS Rural Health Transformation funding announced for all 50 states
- Duke Health updates visitor guidelines due to respiratory illness spread
- Tri-City Cardiology ASC surpasses 6,000 procedures
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement